News & Announcements
Gliknik Licensee Pfizer Receives Drug Designation from FDA
August 10, 2015
GLIKNIK LICENSEE PFIZER RECEIVES ORPHAN DRUG DESIGNATION FROM U.S. FOOD AND DRUG ADMINISTRATION FOR DRUG CANDIDATE DIRECTED TOWARDS RARE NEUROLOGICAL DISORDER
–FDA grants GL-2045, a recombinant IVIG-mimetic, orphan drug status for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) –
Click the blue press release button below.